Acarix Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Aamir Mahmood
Chief executive officer
SEK 5.6m
Total compensation
| CEO salary percentage | 82.33% |
| CEO tenure | 2.1yrs |
| CEO ownership | n/a |
| Management average tenure | 2.1yrs |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2025 | n/a | n/a | -SEK 48m |
| Sep 30 2025 | n/a | n/a | -SEK 52m |
| Jun 30 2025 | n/a | n/a | -SEK 62m |
| Mar 31 2025 | n/a | n/a | -SEK 65m |
| Dec 31 2024 | SEK 6m | SEK 5m | -SEK 66m |
Compensation vs Market: Aamir's total compensation ($USD595.38K) is about average for companies of similar size in the US market ($USD578.00K).
Compensation vs Earnings: Insufficient data to compare Aamir's compensation with company performance.
CEO
Aamir Mahmood (49 yo)
Mr. Aamir Mahmood serves as President and Chief Executive Officer of Acarix AB (publ) since February 1, 2024. He serves as General Manager/Vice President Americas of MicroPort CRM. He has experience in cor...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & CEO | 2.1yrs | SEK 5.57m | no data | |
| CFO & Executive VP | 10.2yrs | SEK 2.28m | 0% $ 0 | |
| Head of Operations & Customer Excellence | no data | no data | no data | |
| Chief Medical Advisor | 2.2yrs | no data | 0% $ 0 | |
| Head of US Finance | 1.2yrs | no data | 0% $ 0 | |
| Head of Global Strategy & Therapy Development | 1.2yrs | no data | no data |
Experienced Management: ACIX.F's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 5.8yrs | SEK 345.00k | no data | |
| Director & Member of the Advisory Board | 2.1yrs | SEK 471.00k | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Medical Advisor | 2.6yrs | no data | no data | |
| Member of the Advisory Board | 2.1yrs | no data | no data | |
| Member of the Advisory Board | 2.1yrs | no data | no data | |
| Chairman of Board | less than a year | no data | no data | |
| Independent Director | 1.8yrs | SEK 247.00k | 0% $ 0 |
Experienced Board: ACIX.F's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/13 11:51 |
| End of Day Share Price | 2026/03/10 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Acarix AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Savin | Edison Investment Research |
| Ludvig Svensson | Redeye |
| Filip Einarsson | Redeye |